Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 1995 Nov;42(11):1027-30.
doi: 10.1007/BF03011077.

Neuroleptic malignant-like syndrome: a complication of acute organophosphate poisoning

Affiliations
Case Reports

Neuroleptic malignant-like syndrome: a complication of acute organophosphate poisoning

G Ochi et al. Can J Anaesth. 1995 Nov.

Abstract

We report a 60-yr-old woman with schizophrenia, who manifested a neuroleptic malignant (NM)-like syndrome after acute organophosphate poisoning (OPP). She attempted suicide by ingesting 40% emulsions of DMTP (S-2,3-dihydro-5-methoxy-2-oxo-1,3,4-thiadizol-3-yl-methyl O,O-dimethyl phosphorodithioate) 100 ml. On admission, she was unconscious and demonstrated convulsions, depressed respiratory movements, miosis and profuse salivation. Plasma cholinesterase concentration (842 IU.L-1) was very low and OPP was diagnosed. She was treated with gastric lavage, atropine and pralidoxime (PAM). By the seventh day after admission, symptoms of OPP disappeared and serum ChE had recovered to a sub-normal level. On the 13th day, she demonstrated coma, high fever (41.0 degrees C) and lead-pipe rigidity. Serum CPK was increased (1631 IU.L-1). Dantrolene sodium iv was administered for three days. Body temperature began to decrease in 24 hr, and her consciousness, muscle rigidity and other neurological symptoms returned to normal by the 16th day after admission. She was discharged from the hospital without sequelae 55 days after admission. We conclude that OPP can predispose to an NM-like syndrome and that dantrolene may be effective in the management.

PubMed Disclaimer

References

    1. Am J Psychiatry. 1985 Oct;142(10):1137-45 - PubMed
    1. JAMA. 1985 Nov 15;254(19):2792-5 - PubMed
    1. Crit Care Med. 1989 Oct;17(10):1075-6 - PubMed
    1. Neurology. 1981 Aug;31(8):1022-5 - PubMed
    1. Am J Psychiatry. 1989 Mar;146(3):324-8 - PubMed

Publication types

MeSH terms

LinkOut - more resources